Saccadous, a Scottsdale-based ASU spin-off company, has an eye tracker tech device that uses eye movements to detect neurological diseases, such as Alzheimer’s disease, Cerebral Palsy, Parkinson’s disease and even concussions in a non-invasive manner.
The early-stage startup is using 14 licensed patents from equity partner Dignity Health, and 10 years of research from two doctors, to commercialize the eye movement technology to easily detect these diseases faster and less expensively, said Craig Caffarelli, CEO and co-founder of Saccadous (pronounced like the bug, cicadas).
Help employers find you! Check out all the jobs and post your resume.
